Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model

Cancer vaccine application is limited to specific cancer types because few cancer-associated antigens are known to induce tumor rejection. Accordingly, we assessed the utility of Ad881, an oncolytic adenovirus in which viral replication was strictly regulated by the cancer-specific midkine promoter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamano, Tomoki, Kubo, Shuji, Fukumoto, Miki, Yano, Aya, Mawatari-Furukawa, Yuki, Okamura, Haruki, Tomita, Naohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155634/
https://www.ncbi.nlm.nih.gov/pubmed/28035331
http://dx.doi.org/10.1038/mto.2016.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155634/
https://www.ncbi.nlm.nih.gov/pubmed/28035331
http://dx.doi.org/10.1038/mto.2016.31

Ejemplares similares